 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, March 15, 1999, 19(6):2027-2036
Transport of Trembler-J Mutant Peripheral Myelin Protein 22 Is Blocked in the Intermediate Compartment and Affects the Transport of the Wild-Type Protein by Direct Interaction
Andreas R. Tobler1, Lucia Notterpek1, Roland Naef2, Verdon Taylor2, Ueli Suter2, and Eric M. Shooter1 1 Department of Neurobiology, Stanford University School of Medicine, Stanford, California 94305-5125, and 2 Institute of Cell Biology, Department of Biology, Swiss Federal Institute of Technology, CH-8093, Zurich, Switzerland
Peripheral myelin protein 22 (PMP22) is an integral membrane protein that is essential for the normal formation and maintenance of peripheral myelin. Duplications, deletions, or mutations in the PMP22 gene account for a set of dominantly inherited peripheral neuropathies. The heterozygous Trembler-J (TrJ) genotype in mice is similar genetically to a Charcot-Marie-Tooth disease type 1A pedigree in humans, whereas the homozygous TrJ condition leads to the most severe form of PMP22-associated neuropathies. To characterize the consequences of the TrJ mutation, we labeled wild-type (wt-) and TrJ-PMP22 in the third loop of the protein with different epitope tags and expressed them separately or together in COS7 cells and primary Schwann cells. Here we show that the transport of the mutant TrJ-PMP22 is interrupted in the intermediate compartment, preventing its insertion into the plasma membrane and affecting the morphology of the endoplasmic reticulum. In addition, TrJ-PMP22 forms a heterodimer with the wt-PMP22. This interaction causes a fraction of the wt-PMP22 to be retained with TrJ-PMP22 in the intermediate compartment of COS7 and Schwann cells. The relative stability of a wt-mutant PMP22 heterodimer as compared with the wt-wt PMP22 homodimer may determine whether a particular mutation is semidominant or dominant. The neuropathy itself appears to result both from decreased trafficking of wt-PMP22 to the plasma membrane and from a toxic gain of function via the accumulation of wt- and TrJ-PMP22 in the intermediate compartment.
Key words: PMP22; peripheral neuropathy; myelin; Schwann cells; intermediate compartment; dimerization; protein trafficking; Trembler-J mouse; epitope tag
Copyright © 1999 Society for Neuroscience 0270-6474/99/1962027-10$05.00/0
This article has been cited by other articles:
M M Reilly and M E Shy
Diagnosis and new treatments in genetic neuropathies
J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1304 - 1314.
[Abstract] [Full Text] [PDF]
H. Farhan, V. Reiterer, A. Kriz, H.-P. Hauri, M. Pavelka, H. H. Sitte, and M. Freissmuth
Signal-dependent export of GABA transporter 1 from the ER-Golgi intermediate compartment is specified by a C-terminal motif
J. Cell Sci., March 15, 2008; 121(6): 753 - 761.
[Abstract] [Full Text] [PDF]
S. A. Amici, W. A. Dunn Jr, A. J. Murphy, N. C. Adams, N. W. Gale, D. M. Valenzuela, G. D. Yancopoulos, and L. Notterpek
Peripheral Myelin Protein 22 Is in Complex with {alpha}6beta4 Integrin, and Its Absence Alters the Schwann Cell Basal Lamina
J. Neurosci., January 25, 2006; 26(4): 1179 - 1189.
[Abstract] [Full Text] [PDF]
K. J. Roux, S. A. Amici, B. S. Fletcher, and L. Notterpek
Modulation of Epithelial Morphology, Monolayer Permeability, and Cell Migration by Growth Arrest Specific 3/Peripheral Myelin Protein 22
Mol. Biol. Cell, March 1, 2005; 16(3): 1142 - 1151.
[Abstract] [Full Text] [PDF]
A. Fontanini, R. Chies, E. L. Snapp, M. Ferrarini, G. M. Fabrizi, and C. Brancolini
Glycan-independent Role of Calnexin in the Intracellular Retention of Charcot-Marie-Tooth 1A Gas3/PMP22 Mutants
J. Biol. Chem., January 21, 2005; 280(3): 2378 - 2387.
[Abstract] [Full Text] [PDF]
M. Wadehra, L. Goodglick, and J. Braun
The Tetraspan Protein EMP2 Modulates the Surface Expression of Caveolins and Glycosylphosphatidyl Inositol-linked Proteins
Mol. Biol. Cell, May 1, 2004; 15(5): 2073 - 2083.
[Abstract] [Full Text] [PDF]
S. Mulugeta and M. F. Beers
Processing of Surfactant Protein C Requires a Type II Transmembrane Topology Directed by Juxtamembrane Positively Charged Residues
J. Biol. Chem., November 28, 2003; 278(48): 47979 - 47986.
[Abstract] [Full Text] [PDF]
W.-J. Wang, S. Mulugeta, S. J. Russo, and M. F. Beers
Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative
J. Cell Sci., February 15, 2003; 116(4): 683 - 692.
[Abstract] [Full Text] [PDF]
W.-J. Wang, S. J. Russo, S. Mulugeta, and M. F. Beers
Biosynthesis of Surfactant Protein C (SP-C). SORTING OF SP-C PROPROTEIN INVOLVES HOMOMERIC ASSOCIATION VIA A SIGNAL ANCHOR DOMAIN
J. Biol. Chem., May 24, 2002; 277(22): 19929 - 19937.
[Abstract] [Full Text] [PDF]
S. Sancho, P. Young, and U. Suter
Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A
Brain, November 1, 2001; 124(11): 2177 - 2187.
[Abstract] [Full Text] [PDF]
C.-X. Wang, M. Wadehra, B. C. Fisk, L. Goodglick, and J. Braun
Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity
Blood, June 15, 2001; 97(12): 3890 - 3895.
[Abstract] [Full Text] [PDF]
A. Kabore, W. Wang, S. Russo, and M. Beers
Biosynthesis of surfactant protein C: characterization of aggresome formation by EGFP chimeras containing propeptide mutants lacking conserved cysteine residues
J. Cell Sci., January 1, 2001; 114(2): 293 - 302.
[Abstract] [PDF]
C. Brancolini, P. Edomi, S. Marzinotto, and C. Schneider
Exposure at the Cell Surface Is Required for Gas3/PMP22 To Regulate Both Cell Death and Cell Spreading: Implication for the Charcot-Marie-Tooth Type 1A and Dejerine-Sottas Diseases
Mol. Biol. Cell, September 1, 2000; 11(9): 2901 - 2914.
[Abstract] [Full Text]
A. M. Isaacs, K. E. Davies, A. J. Hunter, P. M. Nolan, L. Vizor, J. Peters, D. G. Gale, D. P. Kelsell, I. D. Latham, J. M. Chase, et al.
Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy
Hum. Mol. Genet., July 22, 2000; 9(12): 1865 - 1871.
[Abstract] [Full Text] [PDF]
S. Niemann, M. W. Sereda, U. Suter, I. R. Griffiths, and K.-A. Nave
Uncoupling of Myelin Assembly and Schwann Cell Differentiation by Transgenic Overexpression of Peripheral Myelin Protein 22
J. Neurosci., June 1, 2000; 20(11): 4120 - 4128.
[Abstract] [Full Text] [PDF]
C. O. Hanemann, D. D'Urso, A. A. W. M. Gabreels-Festen, and H. W. Muller
Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A
Brain, May 1, 2000; 123(5): 1001 - 1006.
[Abstract] [Full Text] [PDF]
J. Kamholz, D. Menichella, A. Jani, J. Garbern, R. A. Lewis, K. M. Krajewski, J. Lilien, S. S. Scherer, and M. E. Shy
Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy
Brain, February 1, 2000; 123(2): 222 - 233.
[Abstract] [Full Text] [PDF]
A. R. Tobler, N. Liu, L. Mueller, and E. M. Shooter
Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22
PNAS, January 8, 2002; 99(1): 483 - 488.
[Abstract] [Full Text] [PDF]
L. Notterpek, K. J. Roux, S. A. Amici, A. Yazdanpour, C. Rahner, and B. S. Fletcher
Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia
PNAS, December 4, 2001; 98(25): 14404 - 14409.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|